The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?-Reference-Cited by-同舟云学术

The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?

Published:2018-05 Issue:5 Volume:29 Page:1099-1107
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Sobrero A.,Grothey A.,Iveson T.,Labianca R.,Yoshino T.,Taieb J.,Maughan T.,Buyse M.,André T.,Meyerhardt J.,Shields A.F.,Souglakos I.,Douillard J.-Y.,Cervantes A.^ORCID

Funder

ESMO

AstraZeneca

Bayer

Merck Serono

GlaxoSmithKline plc

Nippon Boehringer Ingelheim Co., Ltd.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/29/5/1099/31062356/mdy064.pdf

Reference20 articles.

1. Early colon cancer: eSMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Labianca;Ann Oncol,2013

2. Capecitabine plus oxaliplatin compared with fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results of the NO16968 randomized controlled phase III trial;Schmoll;J Clin Oncol,2015

3. Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01;Kidwell;Cancer,2012

4. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry;Mols;J Clin Oncol,2013

5. Persistence of high-dose oxaliplatin-induced neuropathy at long-term follow-up;Pietrangeli;Eur Neurol,2006

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months;European Journal of Cancer;2024-09

2. Impact of the IDEA Collaboration Study on Real-World Practice Patterns of Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Population-Based Study;JCO Oncology Practice;2024-06-24

3. Unraveling the Role of Molecular Profiling in Predicting Treatment Response in Stage III Colorectal Cancer Patients: Insights from the IDEA International Study;Cancers;2023-09-30

4. T-Cell Infiltration and Clonality May Identify Distinct Survival Groups in Colorectal Cancer: Development and Validation of a Prognostic Model Based on The Cancer Genome Atlas (TCGA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC);Cancers;2022-11-29

5. Development and validation of a coding framework to identify severe acute toxicity from systemic anti-cancer therapy using hospital administrative data;Cancer Epidemiology;2022-04